Nanoparticle Delivery of Immunostimulatory Agents for Cancer Immunotherapy

Immunostimulatory agents, including adjuvants, cytokines, and monoclonal antibodies, hold great potential for the treatment of cancer. However, their direct administration often results in suboptimal pharmacokinetics, vulnerability to biodegradation, and compromised targeting. More recently, encapsu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Jia, Holay, Maya, Park, Joon Ho, Fang, Ronnie H., Zhang, Jie, Zhang, Liangfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831474/
https://www.ncbi.nlm.nih.gov/pubmed/31695803
http://dx.doi.org/10.7150/thno.37216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831474/
https://www.ncbi.nlm.nih.gov/pubmed/31695803
http://dx.doi.org/10.7150/thno.37216

Ejemplares similares